Literature DB >> 28286199

Abnormalities of the Bone Marrow Immune Microenvironment in Patients with Prolonged Isolated Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation.

Yang Song1, Min-Min Shi1, Yuan-Yuan Zhang2, Xiao-Dong Mo2, Yu Wang2, Xiao-Hui Zhang2, Lan-Ping Xu2, Xiao-Jun Huang1, Yuan Kong3.   

Abstract

Prolonged isolated thrombocytopenia (PT) is a serious complication after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Whether abnormalities of the bone marrow (BM) immune microenvironment are involved in the pathogenesis of PT remains unknown, however. Twenty patients with PT, 40 matched patients with good graft function (GGF) after allo-HSCT, and 20 healthy donors (HD) were enrolled in this nested case-control study. Th1, Th2, Tc1, Tc2, Th17, and Treg cells were analyzed by flow cytometry, and IFN-γ, IL-4, IL-17, IL-6, IL-21, and thrombopoietin levels in BM plasma were evaluated with a cytometric bead assay and ELISA. Relative to GGF patients and HD controls, PT patients had significantly higher proportions of Th1 and Tc1 cells, resulting in higher Th1/Th2 and Tc1/Tc2 ratios in the BM microenvironment. In addition, the excessive polarization of Th17 was observed in patients with PT. Changes in BM plasma cytokines were consistent with our cellular findings. These results suggest that dysregulated T cell responses in the BM microenvironment might play an important role in the pathogenesis of PT.
Copyright © 2017 The American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allogeneic hematopoietic stem cell transplantation; Bone marrow immune microenvironment; Prolonged isolated thrombocytopenia

Mesh:

Substances:

Year:  2017        PMID: 28286199     DOI: 10.1016/j.bbmt.2017.02.021

Source DB:  PubMed          Journal:  Biol Blood Marrow Transplant        ISSN: 1083-8791            Impact factor:   5.742


  10 in total

1.  Prophylactic oral NAC reduced poor hematopoietic reconstitution by improving endothelial cells after haploidentical transplantation.

Authors:  Yuan Kong; Yu Wang; Yuan-Yuan Zhang; Min-Min Shi; Xiao-Dong Mo; Yu-Qian Sun; Ying-Jun Chang; Lan-Ping Xu; Xiao-Hui Zhang; Kai-Yan Liu; Xiao-Jun Huang
Journal:  Blood Adv       Date:  2019-04-23

2.  Eltrombopag in the treatment of patients with persistent thrombocytopenia after haploidentical peripheral blood stem cell transplantation: a single-center experience.

Authors:  Fei Yan; Ning Lu; Zhenyang Gu; Wenrong Huang; Shuhong Wang; Xiaoning Gao; Liping Dou; Fei Li; Lili Wang; Meng Li; Daihong Liu; Chunji Gao
Journal:  Ann Hematol       Date:  2021-11-04       Impact factor: 3.673

3.  Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Lidan Zhu; Jia Liu; Peiyan Kong; Shichun Gao; Lu Wang; Huanfeng Liu; Cheng Zhang; Li Gao; Yimei Feng; Ting Chen; Lei Gao; Xi Zhang
Journal:  Front Immunol       Date:  2022-05-27       Impact factor: 8.786

4.  Improved function and balance in T cell modulation by endothelial cells in young people.

Authors:  Shu-Qian Tang; Wei-Li Yao; Ya-Zhe Wang; Yuan-Yuan Zhang; Hong-Yan Zhao; Qi Wen; Yu Wang; Lan-Ping Xu; Xiao-Hui Zhang; Xiao-Jun Huang; Yuan Kong
Journal:  Clin Exp Immunol       Date:  2021-08-22       Impact factor: 4.330

5.  Evaluation of blood vessel injury, oxidative stress and circulating inflammatory factors in an L-NAME-induced preeclampsia-like rat model.

Authors:  Wen Shu; Hanying Li; Hao Gong; Mei Zhang; Xiulong Niu; Yongqiang Ma; Xin Zhang; Wei Cai; Guohong Yang; Maoti Wei; Ning Yang; Yuming Li
Journal:  Exp Ther Med       Date:  2018-05-24       Impact factor: 2.447

Review 6.  Hematopoietic Stem Cell Niche During Homeostasis, Malignancy, and Bone Marrow Transplantation.

Authors:  Yan Man; Xiangmei Yao; Tonghua Yang; Yajie Wang
Journal:  Front Cell Dev Biol       Date:  2021-01-22

Review 7.  Thrombocytopenia and Therapeutic Strategies after Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Leyre Bento; Mariana Canaro; José María Bastida; Antonia Sampol
Journal:  J Clin Med       Date:  2022-03-02       Impact factor: 4.241

8.  Dysfunctional bone marrow endothelial progenitor cells are involved in patients with myelodysplastic syndromes.

Authors:  Tong Xing; Zhong-Shi Lyu; Cai-Wen Duan; Hong-Yan Zhao; Shu-Qian Tang; Qi Wen; Yuan-Yuan Zhang; Meng Lv; Yu Wang; Lan-Ping Xu; Xiao-Hui Zhang; Xiao-Jun Huang; Yuan Kong
Journal:  J Transl Med       Date:  2022-03-29       Impact factor: 5.531

9.  Prognostic Value of Thrombocytopenia in Myelodysplastic Syndromes After Hematopoietic Stem Cell Transplantation.

Authors:  Hong Wang; Jiaqian Qi; Xueqian Li; Tiantian Chu; Huiying Qiu; Chengcheng Fu; Xiaowen Tang; Changgeng Ruan; Depei Wu; Yue Han
Journal:  Front Oncol       Date:  2022-07-11       Impact factor: 5.738

10.  Different subsets of haematopoietic cells and immune cells in bone marrow between young and older donors.

Authors:  W-L Yao; Q Wen; H-Y Zhao; S-Q Tang; Y-Y Zhang; Y Wang; L-P Xu; X-H Zhang; X-J Huang; Y Kong
Journal:  Clin Exp Immunol       Date:  2020-10-21       Impact factor: 4.330

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.